Target intelligence / Profile preview

Lamin A/C protein (Lamin A/C)

Target
Lamin A/C
Molecular classification
Type V intermediate filament protein, Nuclear structural protein, Other
01

Overview

Lamin A/C protein is a structural protein encoded by the LMNA gene in humans, and consists of two major isoforms—lamin A and lamin C—produced via alternative splicing[1][5][8]. Lamin A/C is a type V intermediate filament protein and a critical component of the nuclear lamina, a dense protein meshwork underlying the inner nuclear membrane[1][2][5]. Lamin A/C proteins provide mechanical support to the nucleus, maintain nuclear shape, organize chromatin, and regulate gene expression[3][5][8]. These proteins also play key roles in signal transduction, mechanotransduction, DNA repair, and telomere maintenance[2][3][4]. Mutations or dysregulation of lamin A/C impair nuclear integrity and function, leading to a spectrum of genetic disorders collectively called laminopathies, which include muscular dystrophy, dilated cardiomyopathy, lipodystrophy, and Hutchinson–Gilford progeria syndrome[1][3][5]. Dysregulation of lamin A/C expression is implicated in various cancers and may affect tumor aggressiveness and prognosis[3]. While not a direct therapeutic target, altered lamin A/C levels have potential as biomarkers for certain cancers, such as prostate cancer, or as indicators in genetic disease diagnostics[3].

Other names
Lamin ALamin CLMNA proteinPrelamin-A/C
02

Biological functions

Nuclear structural stabilityChromatin organizationRegulation of gene expressionNuclear mechanotransductionCell motilityCell differentiationDNA damage repairTelomere protectionRegulation of cell cycleMechanosensing
03

Disease associations

Genetic disorders (Laminopathies)Accelerated aging syndromes (e.g., Hutchinson–Gilford progeria syndrome)Muscular dystrophyCardiomyopathyCancer
04

Safety considerations

Mutations can lead to diverse diseases affecting muscle, cardiac, adipose tissues, and premature agingNo evidence for direct therapeutic targeting; thus, no direct pharmacological safety concerns as a target
05

Biomarkers

Potential biomarker for prostate cancer diagnosisDiagnosis of other diseases involving nuclear envelope abnormalities

Beyond the preview

Go deeper on Lamin A/C protein (Lamin A/C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lamin A/C protein (Lamin A/C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call